一种独特有效的CFTR校正器,具有互补的作用模式
Valentina Marchesin1, Lucile Monnier1, Peter Blattmann1
1Idorsia Pharmaceuticals Ltd., 4123 Allschwil, Switzerland.
Science advances
|March 1, 2024
概括
新的宏环化合物作为"IV型"校正剂,在囊性纤维化模型中显著改善F508del-囊性纤维化跨膜导电性调节器 (CFTR) 蛋白质的折叠和功能.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 囊性纤维化 (CF) 是由CFTR基因突变引起的,其中F508del是最常见的.
- 现有的CFTR校正器 (I,II,III型) 部分恢复F508del-CFTR蛋白折叠和贩运.
- 需要具有独特机制的新型CFTR校正剂来完全挽救蛋白质功能.
研究的目的:
- 发现和描述具有独特作用机制的新型宏环CFTR校正剂.
- 阐明这些新的宏循环校正剂的结合部位和机制.
- 评估这些新型化合物对囊性纤维化病的治疗潜力.
主要方法:
- 合成和测试新型宏环化合物作为CFTR校正剂.
- 生物化学测试以评估F508del-CFTR折叠和内分泌网膜的退出.
- 在患者衍生细胞中对CFTR通道功能的电生理学测量.
- 可光激活的交叉连接,分子对接和位点定向的突变发生,以确定结合点.
主要成果:
- 宏环化合物与现有校正剂具有添加效应,作为"IV型"校正剂.
- 这些宏循环对于F508del-CFTR.实现了接近野生类型的折叠效率.
- 在患者衍生的支气管上皮细胞中观察到正常化的CFTR电流.
- 在一个涉及Lh1和MSD1的腔体中,与已知的校正点区分开来,确定了一个独特的结合点.
- 挽救以前对校正剂耐药的CFTR突变物已经实现.
结论:
- 新型宏环化合物代表了一类新的CFTR校正剂,具有独特的"IV型"机制.
- 这些化合物有效地挽救F508del-CFTR折叠和功能,提供显著的治疗潜力.
- 确定了结合部位和结合机制,为进一步开发用于囊性纤维化疾病的药物提供了基础.
相关概念视频
Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K


